Gland Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 14-Aug-2025.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma's Board has approved audited financial results for Q4 and FY ended March 31, 2025, with statutory auditor Deloitte Haskins & Sells issuing an unmodified (clean) opinion. The Board has recommended a final dividend of Rs. 18 per equity share (face value Rs. 1) for FY25, which will be paid within 30 days of the AGM. The record date to identify eligible shareholders is fixed as August 14, 2025, and the 47th AGM is scheduled for August 28, 2025 via video conferencing. The Board also approved the appointment of M/s. RVR & Associates as Secretarial Auditors for a 5-year term starting April 1, 2025, and amended certain policies to align with updated SEBI regulations.
Shareholders holding Gland Pharma shares as of the August 14, 2025 record date will be eligible for the final dividend of Rs. 18 per share, pending AGM approval. The clean audit opinion and continuity of dividend payouts signal financial stability, which is generally positive for investor confidence.